Lv1
78 积分 2021-09-28 加入
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates
28天前
已完结
Overcoming Resistance to Tumor-Targeted and Immune-Targeted Therapies
1个月前
已完结
A Phase II Study of Pazopanib in Patients with Localized Renal Cell Carcinoma to Optimize Preservation of Renal Parenchyma
5个月前
已完结
The Effect of Sunitinib on Primary Renal Cell Carcinoma and Facilitation of Subsequent Surgery
5个月前
已完结
Prospective Clinical Trial of Preoperative Sunitinib in Patients With Renal Cell Carcinoma
5个月前
已完结
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma
5个月前
已完结
Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma
6个月前
已完结
Targeting Tumor-Associated Macrophages and Cancer-Associated Fibroblasts to Overcome Therapeutic Resistance in Hepatocellular Carcinoma
6个月前
已完结
Molecular and therapeutic landscape of non-clear cell renal carcinoma
6个月前
已完结
The Promise of Neoadjuvant and Adjuvant Therapies for Renal Cancer
7个月前
已完结
皖公网安备34019202002308
